Evaluation: the product record review indicated that the reported events do not represent an unanticipated event.Review of the manufacturing documentation confirmed all required in-process and final inspections and testing were completed.Based on this investigation, the investigation conclusion code of 'cause traced to component failure' was chosen because the reported events could be traced to a component failure.Based on the results of this investigation, no escalation is required.This conclusion is supported by the following objective evidence: product analysis summary: product analysis confirmed the reported event related to pump collapse.The ams 700 momentary squeeze (ms) pump was visually inspected.The kink resistant tubing (krt) was worn to the filament; however, no leaks were present.The pump was functionally tested and failed activation test.Product analysis confirmed the reported event.Dhr review / similar complaint review: review of manufacturing documentation was performed to ensure that all required in-process and final inspections and testing were completed.Review of the manufacturing records for batch: 1000072179 and it respective container 21860019, found no evidence that the device failed to meet applicable product specifications prior to shipment from boston scientific.Additionally, potential emerging trends are captured as part of the post market signal evaluation and escalation process.Risk review: the ams 700 hazard analysis indicates that the as reported events of this complaint do not represent a new hazardous situation.Additionally, boston scientific does not have responsibility to provide training to medical professional as documented in the dfu/ifu, and the ams 700 is not a new product because it is not within the first six months of its release in any geography, and it is not a new design platform.No further review is required.
|